Douglas Adkins, M.D.

Trials

Studies that name Douglas Adkins, M.D. as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 08:11 UTC. Open this list on ClinicalTrials.gov

• Ph2
  NCT06702033 · The Minimalist Trial-2

  Washington University School of Medicine · recruiting · HPV-Related Oropharynx Squamous Cell Carcinoma · principal investigator
• Ph3
  NCT04966481 · Palbociclib and Cetuximab Versus Cetuximab Monotherapy for Patients With CDKN2A-altered, HPV-unrelated Head and Neck Squamous Cell Carcinoma Who Experienced Disease Progression on a PD-1/L1 Inhibitor

  Washington University School of Medicine · recruiting · HPV-unrelated Head and Neck Squamous Cell Carcinoma · principal investigator
• Ph2
  NCT04643379 · Olaparib in Combination With Pembrolizumab and Carboplatin as First-Line Treatment of Recurrent or Metastatic Head and Neck Squamous-Cell Carcinoma

  Washington University School of Medicine · active not recruiting · Recurrent Head and Neck Squamous Cell Carcinoma, Metastatic Head and Neck Squamous Cell Carcinoma · principal investigator
• Ph1
  NCT04624113 · Tazemetostat and Pembrolizumab in Patients With Pembrolizumab- or Nivolumab-Resistant, Recurrent or Metastatic Head and Neck Squamous-Cell Carcinoma

  Washington University School of Medicine · terminated · Head and Neck Squamous Cell Carcinoma · principal investigator
• Ph2
  NCT03621696 · Surgery Followed by Risk-Directed Post-Operative Adjuvant Therapy for HPV-Related Oropharynx Squamous Cell Carcinoma: "The Minimalist Trial (MINT)"

  Washington University School of Medicine · completed · HPV Related Oropharyngeal Squamous Cell Carcinoma · principal investigator
• Ph2
  NCT02573493 · Nab-Paclitaxel and Cisplatin or Nab-paclitaxel as Induction Therapy for Locally Advanced Squamous Cell Carcinoma of the Head and Neck (HNSCC)

  Washington University School of Medicine · completed · Squamous Cell Carcinoma of the Head and Neck, Carcinoma, Squamous Cell of the Head and Neck, Cancer of Head and Neck · principal investigator
• Ph1/Ph2
  NCT02101034 · PD 0332991 and Cetuximab in Patients With Incurable SCCHN

  Washington University School of Medicine · completed · Carcinoma, Squamous Cell of Head and Neck · principal investigator
• Ph1
  NCT01716416 · Pazopanib Plus Cetuximab for Incurable Head and Neck Squamous Cell Carcinoma (HNSCC)

  Washington University School of Medicine · completed · Squamous Cell Carcinoma of the Head and Neck · principal investigator
• Ph2
  NCT01566435 · Induction Chemotherapy With ACF Followed by Chemoradiation Therapy for Adv. Head & Neck Cancer

  Washington University School of Medicine · completed · Head and Neck Neoplasms · principal investigator
• Ph2
  NCT01553851 · GSK1120212 in Surgically Resectable Oral Cavity Squamous Cell Cancer

  Washington University School of Medicine · completed · Neoplasms, Oral, Mouth Neoplasms · principal investigator
• Ph2
  NCT00736944 · Trial of 2 Cycles of Induction Chemo With Abraxane, Cetuximab, Cisplatin, & 5-FU for Advanced Head and Neck Cancer

  Washington University School of Medicine · completed · Squamous Cell Carcinoma of the Head and Neck · principal investigator
• Ph2
  NCT00671437 · Determine Tumor Response Using Fluorodeoxyglucose (FDG)- Positron Emission Tomography (PET)/Computed Tomography (CT) Before and After Cetuximab in Patients With Head and Neck Cancer

  Washington University School of Medicine · completed · Carcinoma, Squamous Cell · principal investigator

Grants

NIH projects from RePORTER, fetched 2026-11-12 08:11 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.

No NIH project could be tied to this name by a shared trial or a matching institution.